共 50 条
Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study
被引:42
|作者:
Syrigos, Konstantinos
[1
]
Grapsa, Dimitra
[1
]
Sangare, Rabiatou
[2
]
Evmorfiadis, Ilias
[2
]
Larsen, Annette K.
[2
]
Van Dreden, Patrick
[3
]
Boura, Paraskevi
[1
]
Charpidou, Andriani
[1
]
Kotteas, Elias
[1
]
Sergentanis, Theodoros N.
[4
]
Elalamy, Ismail
[2
,5
]
Falanga, Anna
[6
,7
]
Gerotziafas, Grigoris T.
[2
,5
]
机构:
[1] Univ Athens, Dept Med 3, Oncol Unit, Sch Med,Sotiria Gen Hosp, Athens, Greece
[2] Sorbonne Univ, Fac Med, Ctr Rech St Antoine, Canc Biol & Therapeut,INSERM,U938,IUC, Paris, France
[3] Diagnost Stago, Clin Res Dept, Gennevilliers, France
[4] Hop Univ Est Parisien, Hop Tenon, AP HP, Serv Hematol Biol, Paris, France
[5] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece
[6] ASST Papa Giovanni XXIII, Dept Immunohematol & Transfus Med, Bergamo, Italy
[7] ASST Papa Giovanni XXIII, Hemostasis & Thrombosis Ctr, Bergamo, Italy
来源:
关键词:
Lung cancer;
Venous thromboembolism;
Thrombin generation;
Cancer-associated thrombosis;
Risk assessment model;
PATIENTS RECEIVING CHEMOTHERAPY;
VENOUS THROMBOEMBOLISM VTE;
PREDICTION;
VALIDATION;
SCORE;
PROPHYLAXIS;
ISSUES;
D O I:
10.1634/theoncologist.2017-0530
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background The aim of this prospective study was to identify the most clinically relevant hypercoagulability biomarkers in lung adenocarcinoma patients for elaboration of an improved risk assessment model (RAM) for venous thromboembolism (VTE). Subjects, Materials, and Methods Results One hundred fifty ambulatory patients with lung adenocarcinoma were prospectively enrolled. Thrombin generation, procoagulant phospholipid-dependent clotting time (Procoag-PPL), tissue factor activity (TFa), factor VIIa (FVIIa), factor V (FV), antithrombin, D-Dimers, P-selectin, and heparanase levels were assessed in platelet-poor plasma at inclusion (baseline) and at the end of the third chemotherapy cycle (third chemotherapy). Cox regression analysis was used to identify independent VTE predictors. At baseline, patients had significantly attenuated thrombin generation, shorter Procoag-PPL, higher levels of TFa, D-Dimers, and heparanase, and lower levels of FVIIa and P-selectin, compared with controls. A significant increase in Procoag-PPL, FV, and FVIIa and a decrease of P-selectin levels were observed between baseline and third chemotherapy. Hospitalization within the last 3 months prior to assessment, time since cancer diagnosis less than 6 months, mean rate index (MRI) of thrombin generation, and Procoag-PPL were independently associated with symptomatic VTE. Accordingly, a prediction model including Procoag-PPL and MRI showed significant discriminating capacity (area under the curve: 0.84). Conclusion Implications for Practice Ambulatory patients with lung adenocarcinoma may display pronounced blood hypercoagulability due to decreased Procoag-PPL, increased endothelial cell activation, and increased degradation of fibrin. Incorporation of Procoag-PPL and MRI of thrombin generation may improve the accuracy of a VTE-RAM in the above setting.
引用
收藏
页码:1372 / 1381
页数:10
相关论文